Výsledky vyhledávání - "B. McGuiness"

Akademický článek

Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019

Autor: Brandon J. Patterson, Chi-Chang Chen, Catherine B. McGuiness, Lisa I. Glasser, Kainan Sun, Philip O. Buck

Publikováno v: Human Vaccines & Immunotherapeutics, Vol 17, Iss 8, Pp 2482-2487 (2021)

Shingrix (Recombinant zoster vaccine, RZV) was approved in October 2017 in the United States (US) for the prevention of herpes zoster in adults aged 50 years and older. The vaccine is administered in two doses, with the second dose administration rec

Externí odkaz: https://doaj.org/article/bd2f14ee610347a897c679c0756248fc

Zobrazit plný text záznamu

Real-world characteristics of patients with sickle cell disease who initiated crizanlizumab therapy

Autor: Payal C. Desai, Chi-Chang Chen, Catherine B. McGuiness, Marie Yasuda, Soyon Lee, Jincy Paulose, Jing He, Glorian Yen

Publikováno v: Current Medical Research and Opinion. 39:555-565

To provide real-word evidence of patients with SCD initiating crizanlizumab, their use of other SCD treatments, and crizanlizumab treatment patterns. Using IQVIA’s US-based, Longitudinal Patient-Centric Pharmacy and Medical Claims Databases patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1945fdb62ec1735a182dd708b2e4a479
https://doi.org/10.1080/03007995.2023.2185391

Zobrazit plný text záznamu

Burden of chemotherapy in patients with relapsed/refractory acute myeloid leukemia in the United States: a retrospective claims database study

Autor: Bhavik J. Pandya, Chi-Chang Chen, Catherine B. McGuiness, Loretta Sullivan, Qi Feng, Elise Walsh, Uma Borate

Publikováno v: Expert Review of Hematology. 15:857-866

Real-world estimates of relapsed or refractory (R/R) acute myeloid leukemia (AML) chemotherapy episode costs are scarce. We quantified chemotherapy episode-related costs and healthcare resource use (HRU) in R/R AML.This real-world, retrospective anal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050bd3c8b42e3ac1da1c527cf0603704
https://doi.org/10.1080/17474086.2022.2104709

Zobrazit plný text záznamu

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States

Autor: Mohammad Jahanzeb, Huamao M Lin, Yanyu Wu, Pingkuan Zhang, Magdaliz Gorritz, Catherine B McGuiness, Wei-Ti Huang, Kainan Sun, Chi-Chang Chen, D Ross Camidge

Publikováno v: The Oncologist. 27:790-798

Background Real-world evidence for brigatinib, a next-generation anaplastic lymphoma kinase-tyrosine kinase inhibitor (ALK-TKI) used in ALK-rearranged non-small cell lung cancer, is scarce. This retrospective study evaluated real-world brigatinib uti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b1f755461b4f22ca68f3a6eced65469
https://doi.org/10.1093/oncolo/oyac116

Zobrazit plný text záznamu

Lipid-Lowering Therapy Utilization and Dosage Among Patients with Acute Coronary Syndrome Events: A Retrospective Cohort from 12 Community Hospitals

Autor: Rasha Khatib, Eric J Yeh, Nicole Glowacki, Catherine B McGuiness, Handing Xie, Rolin L Wade, Bethany A Kalich, Yi Li, Abdelhadi Rifai, Neal Sawlani

Publikováno v: Clinical Epidemiology.

Rasha Khatib,1 Eric J Yeh,2 Nicole Glowacki,1 Catherine B McGuiness,3 Handing Xie,4 Rolin L Wade,4 Bethany A Kalich,5 Yi Li,6 Abdelhadi Rifai,7 Neal Sawlani8 1Academic Research and Strategic Partnership, Advocate Aurora Research Institute, Advocate A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7118f6f59d1fc2b0c7cdd398bf1af5a
https://www.dovepress.com/lipid-lowering-therapy-utilization-and-dosage-among-patients-with-acut-peer-reviewed-fulltext-article-CLEP

Zobrazit plný text záznamu

Clinical and Economic Burden of Glaucoma by Disease Severity

Autor: Mousam Parekh, Joanna Campbell, Vanessa Shih, Mildred M.G. Olivier, Jasjit K. Multani, Eydie Miller-Ellis, Catherine B McGuiness, Chi-Chang Chen

Publikováno v: Ophthalmology Glaucoma. 4:490-503

PURPOSE To provide updated estimates of the clinical and economic burden in patients with ocular hypertension (OHT) or open-angle glaucoma (OAG) by disease severity in the United States and to estimate incremental costs associated with disease progre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e4f9545ae6c677019c803e618a25523e
https://doi.org/10.1016/j.ogla.2020.12.007

Zobrazit plný text záznamu

Clinical and economic burden of neovascular age-related macular degeneration by disease status: a US claims-based analysis

Autor: Katelyn R Keyloun, Catherine B McGuiness, Bijal Shah-Manek, Arghavan Almony, Chi-Chang Chen, Jasjit K. Multani, Joanna Campbell

Publikováno v: Journal of Managed Care & Specialty Pharmacy. 27:1260-1272

BACKGROUND: New treatment alternatives have revolutionized the management of nAMD. However, there is limited evidence on the clinical and economic burden of nAMD in commercially insured US patients...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5705f10286412453176c098c6ce1fd55
https://doi.org/10.18553/jmcp.2021.27.9.1260

Zobrazit plný text záznamu

Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records

Autor: Xin Wang, Dhaval Patil, Catherine B. McGuiness, Paul S. Yamauchi, Elizabeth Nguyen, Yi Wang, Chi-Chang Chen, Eugenia Levi, April W. Armstrong

Publikováno v: Dermatology and Therapy

Introduction Information on the long-term treatment satisfaction with secukinumab for patients with plaque psoriasis in real-world settings is limited. The objective of this study was to describe real-world treatment satisfaction in patients with pla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cb3e77410e6eb2134157368256e804b
https://doi.org/10.1007/s13555-021-00599-5

Zobrazit plný text záznamu

Plný text ve formátu HTML

Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

Autor: Chi-Chang Chen, Shonda A. Foster, Wenyu Ye, Catherine B McGuiness, Timothy R Smith, Shivang Joshi, Rolin L Wade, Oksana Mason, Paula C. Morrow, Yao Ding

Publikováno v: Journal of Medical Economics. 23:1356-1364

To evaluate the prevalence and risk factors of migraine progression and to assess the incremental burden of migraine progression on healthcare systems.Adult patients were required to have a migraine diagnosis in IQVIA's US adjudicated claims database

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b18ad5aecae5d15496efa7d0284950
https://doi.org/10.1080/13696998.2020.1814790

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání